19P Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation

2021 ◽  
Vol 32 ◽  
pp. S1351
Author(s):  
I. Dogan ◽  
M. Gürbüz ◽  
N. Paksoy ◽  
N. Khanmamadov ◽  
S. Vatansever ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Resistance Mutation ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Mutant

scholarly journals Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients

2007 ◽  
Vol 22 (3) ◽  
pp. 178 ◽  
Author(s):  
Yoon Ho Ko ◽  
Myung Ah Lee ◽  
Yeong Seon Hong ◽  
Kyung Shik Lee ◽  
Hyun Jin Park ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients

Lung Cancer ◽  
2009 ◽  
Vol 63 (2) ◽  
pp. 251-258 ◽  
Author(s):  
Vittorio Gebbia ◽  
Cesare Gridelli ◽  
Claudio Verusio ◽  
Luciano Frontini ◽  
Enrico Aitini ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Combination Chemotherapy ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Weekly Docetaxel

P-523 Phase II trial of BBR3464, a novel, bifunctional platinum analog, as second line treatment of non-small cell lung cancer patients

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S223 ◽  
Author(s):  
Giorgio Scagliotti ◽  
Silvia Novello ◽  
Lucio Crinò ◽  
Filippo De Marinis ◽  
Maurizio Tonato ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung ◽  
Lung Cancer Patients

scholarly journals Tumor Volume Decrease at 8 Weeks Is Associated with Longer Survival in EGFR-Mutant Advanced Non–Small-Cell Lung Cancer Patients Treated with EGFR TKI

2013 ◽  
Vol 8 (8) ◽  
pp. 1059-1068 ◽  
Author(s):  
Mizuki Nishino ◽  
Suzanne E. Dahlberg ◽  
Stephanie Cardarella ◽  
David M. Jackman ◽  
Michael S. Rabin ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Tumor Volume ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Mutant ◽  
Egfr Tki ◽  
Volume Decrease
Sign in / Sign up

Export Citation Format

Share Document